bims-rebome Biomed News
on Rehabilitation of bone metastases
Issue of 2026–01–18
three papers selected by
Alberto Selvanetti, Azienda Ospedaliera San Giovanni Addolorata



  1. Spine (Phila Pa 1976). 2026 Jan 12.
    JASA Study Group
       STUDY DESIGN: Large multicenter prospective study.
    OBJECTIVE: We aimed to develop and validate a novel machine learning-based prognostic scoring system for spinal metastases.
    SUMMARY OF BACKGROUND DATA: Spinal metastases, common complications in patients with advanced cancer, significantly affect neurological function, pain, and quality of life. Although surgery plays a crucial role in selected cases, the accurate prediction of patient prognosis remains challenging. Traditional scoring systems, developed for older treatment paradigms, do not fully reflect the impact of modern oncologic therapies.
    METHODS: This multicenter prospective study, conducted by the Japan Association of Spine Surgeons with Ambition, included 401 patients who underwent surgery for spinal metastases at 35 medical centers between 2018 and 2021. Patient demographics, tumor burden, performance status, and treatment history data were collected. Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression was used to identify significant predictors of one-year survival, followed by stepwise variable selection. The model performance was assessed using the area under the receiver operating characteristic curve (AUROC) and calibration plots.
    RESULTS: Among the 401 patients, 67.1% survived for one year, whereas 32.9% did not. Survivors had better performance status, lower tumor burden, and lower opioid use than non-survivors. LASSO regression identified five key predictors of one-year survival: age ≥75 years, poor performance status (≥3), presence of other bone metastases, preoperative opioid use, and lower preoperative Vitality Index. The final model demonstrated a strong predictive performance (AUROC=0.762). Based on the key prognostic factors, a simplified risk stratification system was developed to classify patients into low- (one-year survival 82.2%), intermediate- (67.2%), and high-risk (34.2%) groups.
    CONCLUSION: We developed a clinically applicable prognostic scoring system for patients with spinal metastases using machine learning techniques to enhance predictive accuracy. This model provides a practical risk assessment tool to aid surgical decision-making and optimize postoperative management.
    LEVEL OF EVIDENCE: 2.
    Keywords:  LASSO logistic regression; machine learning; modern oncologic therapies; multicenter prospective dataset; preoperative opioid use; prognostic factors; prognostic scoring; risk stratification system; spinal metastasis; vitality index
    DOI:  https://doi.org/10.1097/BRS.0000000000005603
  2. Am J Cancer Res. 2025 ;15(12): 5183-5198
      The spine is a common site for metastases in lung cancer. Precise identification of factors associated with survival and reliable prediction of prognosis are essential for clinical decision-making in patients with spinal metastasis from lung cancer. A retrospective analysis was conducted on 148 lung cancer patients with spinal metastases between January 2018 and December 2020 to identify prognostic factors and develop a nomogram for predicting survival outcomes. Another 30 patients with spinal metastases due to lung cancer, treated between January 2021 and February 2022, served as an external validation cohort to assess the nomogram's predictive performance. Multivariate analysis identified Karnofsky Performance Status (KPS) score, carbohydrate antigen 125 (CA125), radiotherapy, chemotherapy, and targeted therapy as independent prognostic factors. The nomogram achieved a concordance index of 0.713. The AUCs for the nomogram in predicting 1-, 2-, and 3-year survival were 0.834, 0.750, and 0.733 in the training set; 0.803, 0.738, and 0.713 in the internal validation set; and 0.749, 0.738, and 0.729 in the external validation set. Calibration curves showed good agreement between predicted and observed outcomes. Compared with the modified Tokuhashi and Tomita scores, the nomogram demonstrated superior predictive accuracy and provided greater net clinical benefit in decision curve analysis, indicating good clinical utility. This model may aid individualized prognosis assessment and treatment planning in lung cancer patients with spinal metastases.
    Keywords:  Lung cancer; predictive model; prognostic factors; spinal metastases; survival analysis
    DOI:  https://doi.org/10.62347/RGGC5283
  3. Br J Radiol. 2026 Jan 13. pii: tqag010. [Epub ahead of print]
      Interventional oncology has gained a lot of traction as an attractive alternative treatment for various musculoskeletal tumors by offering minimally invasive image-guided therapies. In this domain, thermal ablation is increasingly being used malignant tumors, including bone metastatic disease. Thermal ablation therapies such as radiofrequency ablation, microwave ablation, cryoablation and high intensity focused ultrasound therapy achieve excellent local tumor control and pain palliation, whilst structural stability is ensured through the combination with bone augmentation techniques such as standard or reinforced osteoplasty. Many factors are affecting the results including the biology of the disease the treatment intent (curative or palliative) as well as the potential for complications, like thermal injury to surrounding tissues, highlight the need for meticulous procedural planning. This review highlights the pathophysiology, the current repertoire of thermal ablation techniques, clinical outcomes and the future directions for the treatment of metastatic bone disease.
    Keywords:  augmentation; bone metastases; cancer; microwave ablation; pain; radiofrequency ablation; thermal ablation
    DOI:  https://doi.org/10.1093/bjr/tqag010